Omda Temettü

Temettü kriter kontrolleri 0/6

Omda 1.49% cari getiri oranına sahip temettü ödeyen bir şirkettir.

Anahtar bilgiler

1.5%

Temettü verimi

3.2%

Geri Alım Getirisi

Toplam Hissedar Getirisi	4.6%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	NOK 0.477
Ödeme oranı	11%

Son temettü güncellemeleri

Recent updates

Returns At Omda (OB:OMDA) Are On The Way Up

Jul 24

Omda's (OB:OMDA) Earnings Are Weaker Than They Seem

May 22

Improved Revenues Required Before Omda AS (OB:OMDA) Stock's 28% Jump Looks Justified

Mar 24

Here's What CSAM Health Group AS' (OB:CSAM) Shareholder Ownership Structure Looks Like

Feb 14

CSAM Health Group AS' (OB:CSAM) Has Found A Path To Profitability

Jan 10

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: OMDA Norwegian piyasası için dikkate değer bir temettü ödemesi yapmıyor, bu nedenle ödemelerin istikrarlı olup olmadığını kontrol etmeye gerek yok.

Büyüyen Temettü: OMDA Norwegian piyasası için dikkate değer bir temettü ödemiyor, bu nedenle ödemelerin artıp artmadığını kontrol etmeye gerek yok.

Piyasaya Karşı Temettü Getirisi

Omda Piyasaya Karşı Temettü Getirisi

OMDA temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (OMDA)	1.5%
Pazarın Alt %25'i (NO)	3.3%
Pazarın En İyi %25'i (NO)	7.5%
Sektör Ortalaması (Healthcare Services)	2.9%
Analist tahmini (OMDA) (3 yıla kadar)	0%

Önemli Temettü: OMDA şirketinin temettüsü ( 1.49% ), Norwegian pazarındaki temettü ödeyenlerin en alttaki %25'ine ( 3.28% ) kıyasla dikkate değer değil.

Yüksek Temettü: OMDA 'in temettüsü ( 1.49% ), Norwegian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 7.53% ) kıyasla düşüktür.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: OMDA Norwegian piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: OMDA Norwegian piyasası için dikkate değer bir temettü ödemiyor.

Omda Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Omda AS (OB:OMDA) commences an Equity Buyback Plan under the authorization approved on April 25, 2024.

CSAM Health Group AS (OB:CSAM) commences an Equity Buyback Plan under the authorization approved on May 19, 2022.

Recent updates

Consensus EPS estimates have been downgraded.

Consensus EPS estimates have been downgraded.

Consensus EPS estimates increase from loss to kr0.7777 profit, revenue downgraded

Price target decreased by 9.2% to kr44.50

Second quarter 2024 earnings released

Returns At Omda (OB:OMDA) Are On The Way Up

Consensus EPS estimates have been downgraded.

Omda AS (OB:OMDA) commences an Equity Buyback Plan under the authorization approved on April 25, 2024.

Investor sentiment improves as stock rises 19%

Omda's (OB:OMDA) Earnings Are Weaker Than They Seem

First quarter 2024 earnings released

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase from loss to kr0.449 profit

Improved Revenues Required Before Omda AS (OB:OMDA) Stock's 28% Jump Looks Justified

Price target decreased by 10% to kr49.00

Full year 2023 earnings released: EPS: kr5.04 (vs kr6.28 loss in FY 2022)

Investor sentiment deteriorates as stock falls 20%

New major risk - Share price stability

Fewer Investors Than Expected Jumping On Omda AS (OB:OMDA)

Omda AS, Annual General Meeting, Apr 25, 2024

Consensus EPS estimates have been upgraded.

Omda's (OB:OMDA) Earnings May Just Be The Starting Point

Investor sentiment improves as stock rises 26%

Third quarter 2023 earnings released

No longer forecast to breakeven

Omda AS to Report Q2, 2024 Results on Aug 23, 2024

Forecast to breakeven in 2025

New major risk - Revenue and earnings growth

Forecast to breakeven in 2025

Second quarter 2023 earnings released

Are Investors Undervaluing CSAM Health Group AS (OB:CSAM) By 44%?

Consensus EPS estimates fall by 29%

Price target increased by 8.8% to kr61.50

Full year 2022 earnings released

CSAM Health Group AS (OB:CSAM) commences an Equity Buyback Plan under the authorization approved on May 19, 2022.

Forecast to breakeven in 2025

CSAM Health Group AS to Report Q4, 2022 Results on Feb 28, 2023

Consensus EPS estimates fall by 16%

Third quarter 2022 earnings released

Price target decreased to kr60.50

No independent directors

Consensus EPS estimates fall by 70%

Price target decreased to kr71.00

Second quarter 2022 earnings released

Consensus EPS estimates fall by 60%

Price target decreased to kr97.00

Full year 2021 earnings: EPS misses analyst expectations

No independent directors

Consensus forecasts updated

Price target decreased to kr116

CSAM Health Group AS (OB:CSAM) acquired Carmona AB for SEK 20 million.

Now 28% undervalued after recent price drop

Consensus EPS estimates fall by 10%

Spigraph Sweden Ab acquired Scanner business in Sweden from CSAM Health Group AS (OB:CSAM).

Insider recently bought kr498k worth of stock

Third quarter 2021 earnings: Revenues in line with analyst expectations

No longer forecast to breakeven

Legal & HR Director Marius Johansen has left the company

CSAM Health Group AS (OB:CSAM) entered in an agreement to acquire Medscinet Ab for SEK 24 million.

Forecast breakeven pushed back to 2022

CSAM Health Group AS (OB:CSAM) Is About To Turn The Corner

Revenue misses expectations

Full year 2020 earnings released

CSAM Health Group AS (OB:CSAM) acquired Public Safety business of Carmenta AB for an enterprise value of SEK 150 million.

Here's What CSAM Health Group AS' (OB:CSAM) Shareholder Ownership Structure Looks Like

New 90-day low: kr80.66

CSAM Health Group AS, Annual General Meeting, May 06, 2021

New 90-day high: kr106

CSAM Health Group AS' (OB:CSAM) Has Found A Path To Profitability

CSAM Health Group AS (OB:CSAM) completed the acquisition of Fertsoft AB for SEK 6.2 million.

CSAM Health Group AS (OB:CSAM) entered into a share purchase agreement to acquire Fertsoft AB for SEK 6 million.

CSAM Health Group AS to Report Q3, 2020 Results on Nov 27, 2020

Ödemelerde İstikrar ve Büyüme